Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Details of Shire Human Genetic Therapies Inc's U.S. FDA Inspections. Original Data: FDA Inspection Database

SHIRE HUMAN GENETIC THERAPIES INC
SHIRE LLC
SHIRE PLC
SCM Pharma
SHIRE DEVELOPMENT
SHIRE ORPHAN THERAP
SHIRE VIROPHARM INC
New River Pharmaceuticals
FDA

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

SHIRE HUMAN GENETIC THERAPIES INC

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

INTERVIEW #SpeakPharma, VLOG #PharmaReel, DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

INTERVIEW #SpeakPharma
VLOG #PharmaReel
DATA COMPILATION #PharmaFlow
2 NEWS #PharmaBuzz

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

INSPECTIONS & REGISTRATIONS

14 FDA

14 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

14 All

01 11SHIRE HUMAN GENETIC THERAPIES INC

02 3Shire Human Genetic Therapies Inc

filter District Decision Reset all filters

14 All

01 4No Action Indicated

02 10Voluntary Action Indicated

filter Inspection End Date Reset all filters

14 All

01 12014-01-30

02 12013-08-05

03 12013-05-23

04 12012-08-31

05 12012-04-02

06 12012-02-01

07 12012-01-11

08 12012-01-06

09 12011-06-02

10 12011-05-19

11 12011-02-16

12 12010-01-07

13 22009-11-20

filter City Reset all filters

14 All

01 2Belmont

02 5Cambridge

03 4Lexington

04 3North Reading

filter Country/Area Reset all filters

14 All

01 14US

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-01-11

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 2139

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-01-11

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-01-06

SHIRE HUMAN GENETIC THERAPIES INC

City : North Reading

State : MA

Country/Area : US

Zip : 1864

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-01-06

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2011-02-16

SHIRE HUMAN GENETIC THERAPIES INC

City : North Reading

State : MA

Country/Area : US

Zip : 1864

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2011-02-16

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-08-31

SHIRE HUMAN GENETIC THERAPIES INC

City : Lexington

State : MA

Country/Area : US

Zip : 2421

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-08-31

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

05

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2009-11-20

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 02138-1100

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2009-11-20

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

06

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2011-05-19

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 02138-1100

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2011-05-19

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

07

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-08-05

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 02138-1100

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-08-05

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

08

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2012-04-02

SHIRE HUMAN GENETIC THERAPIES INC

City : Lexington

State : MA

Country/Area : US

Zip : 2421

District : NWE

Center : CDER

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2012-04-02

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

09

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-01-07

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 2139

District : NWE

Center : CDER

Project Area : Bioresearch Monitoring

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-01-07

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

10

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

FDA Audited

USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-02-01

SHIRE HUMAN GENETIC THERAPIES INC

City : Lexington

State : MA

Country/Area : US

Zip : 2421

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-02-01

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?